{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:13:00Z","timestamp":1790475180184,"version":"4.1.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-GM114180"],"award-info":[{"award-number":["R01-GM114180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00943","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T04:11:38Z","timestamp":1525407098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes"],"prefix":"10.3389","volume":"9","author":[{"given":"Eleonora","family":"Feketeova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Spolarics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jama.298.4.456","article-title":"Caring for the critically ill patient: challenges and opportunities","volume":"298","author":"Angus","year":"2007","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm0503-517","article-title":"Novel strategies for the treatment of sepsis","volume":"9","author":"Riedemann","year":"2003","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.med.56.082103.104356","article-title":"Therapeutic intervention and targets for sepsis","volume":"56","author":"Rice","year":"2005","journal-title":"Annu Rev Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nn.4477","article-title":"Neural regulation of immunity: molecular mechanisms and clinical translation","volume":"20","author":"Pavlov","year":"2017","journal-title":"Nat Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","article-title":"Neural circuitry and immunity","volume":"63","author":"Pavlov","year":"2015","journal-title":"Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molmed.2004.12.007","article-title":"The \u201ccytokine profile\u201d: a code for sepsis","volume":"11","author":"Ulloa","year":"2005","journal-title":"Trends Mol Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.molmed.2017.10.006","article-title":"Nerve stimulation: immunomodulation and control of inflammation","volume":"23","author":"Ulloa","year":"2017","journal-title":"Trends Mol Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1797","article-title":"The vagus nerve and the nicotinic anti-inflammatory pathway","volume":"4","author":"Ulloa","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"B14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00003246-200103000-00006","article-title":"Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","article-title":"Why have clinical trials in sepsis failed?","volume":"20","author":"Marshall","year":"2014","journal-title":"Trends Mol Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0140-6736(02)09459-x","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1172\/JCI42845","article-title":"Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue","volume":"120","author":"Kosteli","year":"2010","journal-title":"J Clin Invest"},{"key":"B19","first-page":"89","article-title":"Energy metabolism in trauma and sepsis: the role of fat","volume":"111","author":"Wolfe","year":"1983","journal-title":"Prog Clin Biol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1172\/jci24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cmet.2007.09.011","article-title":"JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity","volume":"6","author":"Solinas","year":"2007","journal-title":"Cell Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1473-3099(17)30322-5","article-title":"The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study","volume":"17","author":"Machado","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0749-0704(18)30437-8","article-title":"Hypermetabolism-organ failure syndrome: a metabolic response to injury","volume":"5","author":"Cerra","year":"1989","journal-title":"Crit Care Clin"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fimmu.2017.01452","article-title":"The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract","volume":"8","author":"Bonaz","year":"2017","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbabio.2008.04.024","article-title":"Cellular energetic metabolism in sepsis: the need for a systems approach","volume":"1777","author":"Carr\u00e9","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.15585\/mmwr.mm6533e1","article-title":"Vital signs: epidemiology of sepsis: prevalence of health care factors and opportunities for prevention","volume":"65","author":"Novosad","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1097\/ccm.0000000000002590","article-title":"Diabetes is not associated with increased 90-day mortality risk in critically ill patients with sepsis","volume":"45","author":"van Vught","year":"2017","journal-title":"Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/SHK.0b013e3181dc40a8","article-title":"Untreated type 1 diabetes increases sepsis-induced mortality without inducing a prelethal cytokine response","volume":"34","author":"Osuchowski","year":"2010","journal-title":"Shock"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.3748\/wjg.15.4132","article-title":"Blood glucose control in patients with severe sepsis and septic shock","volume":"15","author":"Hirasawa","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/cc7758","article-title":"Neuroimmune perspectives in sepsis","volume":"13","author":"Ulloa","year":"2009","journal-title":"Crit Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2016.12.014","article-title":"Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis","volume":"117","author":"Kanashiro","year":"2017","journal-title":"Pharmacol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph0547s40","article-title":"Streptozotocin-induced diabetic models in mice and rats","author":"Wu","year":"2008","journal-title":"Curr Protoc Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1258\/la.2010.010090","article-title":"Single dose streptozotocin induced diabetes: considerations for study design in islet transplantation models","volume":"45","author":"Deeds","year":"2011","journal-title":"Lab Anim"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/nm1124","article-title":"Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.3479","article-title":"Dopamine mediates vagal modulation of the immune system by electroacupuncture","volume":"20","author":"Torres-Rosas","year":"2014","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.20052362","article-title":"Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis","volume":"203","author":"Huston","year":"2006","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.4049\/jimmunol.1003722","article-title":"Alpha7-nicotinic receptor mediates vagal induction of splenic norepinephrine","volume":"186","author":"Vida","year":"2011","journal-title":"J Immunol"},{"key":"B41","first-page":"356","article-title":"The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources","volume":"61","author":"Graham","year":"2011","journal-title":"Comp Med"},{"key":"B42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3565(25)20252-X","article-title":"Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells","volume":"258","author":"Grenader","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2125.1988.tb03276.x","article-title":"Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients","volume":"25","author":"Weber","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00024382-199801000-00001","article-title":"Animal models of sepsis and shock: a review and lessons learned","volume":"9","author":"Deitch","year":"1998","journal-title":"Shock"},{"key":"B45","doi-asserted-by":"crossref","first-page":"27925","DOI":"10.1016\/S0021-9258(18)46876-7","article-title":"High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype","volume":"269","author":"Tiberi","year":"1994","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev.ne.16.030193.001503","article-title":"Recent advances in the molecular biology of dopamine receptors","volume":"16","author":"Gingrich","year":"1993","journal-title":"Annu Rev Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-\u03baB subunits by phosphorylation","volume":"5","author":"Christian","year":"2016","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd1854","article-title":"Animal models of sepsis: setting the stage","volume":"4","author":"Buras","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"B49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol Res"},{"key":"B50","first-page":"281","article-title":"Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients","volume":"1","author":"Carton","year":"1992","journal-title":"Eur J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fendo.2017.00271","article-title":"Diabetes and sepsis: risk, recurrence, and ruination","volume":"8","author":"Frydrych","year":"2017","journal-title":"Front Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/dc17-2131","article-title":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study","volume":"41","author":"Carey","year":"2018","journal-title":"Diabetes Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.2337\/db11-0825","article-title":"alpha1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice","volume":"61","author":"Spiller","year":"2012","journal-title":"Diabetes"},{"key":"B54","first-page":"22","article-title":"Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes","volume":"1","author":"Jacob","year":"2008","journal-title":"Int J Clin Exp Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/154405910508400406","article-title":"Inflammation is more persistent in type 1 diabetic mice","volume":"84","author":"Graves","year":"2005","journal-title":"J Dent Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.0022-202X.2004.22711.x","article-title":"Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation","volume":"123","author":"Naguib","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/j.micinf.2006.04.021","article-title":"Exacerbation of group B streptococcal sepsis and arthritis in diabetic mice","volume":"8","author":"Puliti","year":"2006","journal-title":"Microbes Infect"},{"key":"B58","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/CCM.0b013e3181958b1c","article-title":"Influence of vasopressor agent in septic shock mortality. Results from the Portuguese community-acquired sepsis study (SACiUCI study)","volume":"37","author":"Povoa","year":"2009","journal-title":"Crit Care Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/01.CCM.0000201896.45809.E3","article-title":"Does dopamine administration in shock influence outcome? Results of the sepsis occurrence in acutely ill patients (SOAP) study","volume":"34","author":"Sakr","year":"2006","journal-title":"Crit Care Med"},{"key":"B60","first-page":"282","article-title":"Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans","volume":"45","author":"Olsen","year":"1998","journal-title":"Dan Med Bull"},{"key":"B61","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00134-006-0084-y","article-title":"Dopamine affects cellular immune functions during polymicrobial sepsis","volume":"32","author":"Oberbeck","year":"2006","journal-title":"Intensive Care Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0165-5728(01)00459-3","article-title":"Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism","volume":"122","author":"Hasko","year":"2002","journal-title":"J Neuroimmunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1677\/joe.0.1440457","article-title":"Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice","volume":"144","author":"Hasko","year":"1995","journal-title":"J Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-2478(96)02494-7","article-title":"Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice","volume":"49","author":"Hasko","year":"1996","journal-title":"Immunol Lett"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0306-4522(95)00215-5","article-title":"Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes","volume":"68","author":"Vizi","year":"1995","journal-title":"Neuroscience"},{"key":"B66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","article-title":"NF-kappaB and the immune response","volume":"25","author":"Hayden","year":"2006","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1084\/jem.189.11.1839","article-title":"The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis","volume":"189","author":"Li","year":"1999","journal-title":"J Exp Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.284.5412.321","article-title":"Severe liver degeneration in mice lacking the IkappaB kinase 2 gene","volume":"284","author":"Li","year":"1999","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1074-7613(00)80042-4","article-title":"Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice","volume":"10","author":"Tanaka","year":"1999","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B","volume":"376","author":"Beg","year":"1995","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20011885","article-title":"Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs","volume":"195","author":"Alcamo","year":"2002","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1073\/pnas.96.6.2994","article-title":"Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality","volume":"96","author":"Doi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/01.shk.0000188710.04777.9e","article-title":"Hmgb-1 as a therapeutic target for infectious and inflammatory disorders","volume":"25","author":"Mantell","year":"2006","journal-title":"Shock"},{"key":"B76","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jss.2012.03.068","article-title":"Long-term effect of trauma splenectomy on blood glucose","volume":"177","author":"Ley","year":"2012","journal-title":"J Surg Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jams.2016.03.009","article-title":"Intraoperative low-frequency electroacupuncture under general anesthesia improves postoperative recovery in a randomized trial","volume":"9","author":"Grech","year":"2016","journal-title":"J Acupunct Meridian Stud"},{"key":"B78","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.4049\/jimmunol.148.9.2724","article-title":"Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia","volume":"148","author":"Eskandari","year":"1992","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/72262","article-title":"Protection from septic shock by neutralization of macrophage migration inhibitory factor","volume":"6","author":"Calandra","year":"2000","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nm989","article-title":"Therapeutic effects of lysophosphatidylcholine in experimental sepsis","volume":"10","author":"Yan","year":"2004","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SHK.0b013e31821820d2","article-title":"The anti-inflammatory potential of selective cholinergic agonists","volume":"36","author":"Ulloa","year":"2011","journal-title":"Shock"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:06:37Z","timestamp":1751601997000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":81,"alternative-id":["10.3389\/fimmu.2018.00943"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00943","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"article-number":"943"}}